Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | nefopam | 4450 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | prilocaine | 4906 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | prilocaine | 4906 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | prilocaine | 4906 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | prilocaine | 4906 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | prilocaine | 4906 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | prilocaine | 4906 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | prilocaine | 4906 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | prilocaine | 4906 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | prilocaine | 4906 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | prilocaine | 4906 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | prilocaine | 4906 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | prilocaine | 4906 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | metoclopramide | 4168 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | metoclopramide | 4168 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | metoclopramide | 4168 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | metoclopramide | 4168 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | metoclopramide | 4168 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | hydralazine | 5365247 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | hydralazine | 5365247 | drug-path |